SPIRIVA RESPIMAT Drug Patent Profile

✉ Email this page to a colleague

Spiriva Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. There are seven patents protecting this drug.

This drug has one hundred and sixty-nine patent family members in forty-four countries.

The generic ingredient in SPIRIVA RESPIMAT is tiotropium bromide. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the tiotropium bromide profile page.

< Available with Subscription >

Sign up for a Free Trial

International Patents:	169
US Patents:	7
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	93
Clinical Trials:	27
Patent Applications:	3,327
Drug Prices:	Drug price information for SPIRIVA RESPIMAT
What excipients (inactive ingredients) are in SPIRIVA RESPIMAT?	SPIRIVA RESPIMAT excipients list
DailyMed Link:	SPIRIVA RESPIMAT at DailyMed

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Saskatchewan	Phase 4
Nemours Children's Clinic	Phase 2
Nephron Pharmaceuticals Corporation	Phase 2

SPIRIVA RESPIMAT is protected by seven US patents.

Piston-pumping system having o-ring seal properties
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Blocking device for a locking stressing mechanism having a spring-actuated output drive device
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Device for clamping a fluidic component
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Microstructured high pressure nozzle with built-in filter function
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Container provided with a pressure equalization opening
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Atomizer and method of atomizing fluid with a nozzle rinsing mechanism
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Device for clamping a fluidic component
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Boehringer Ingelheim	SPIRIVA RESPIMAT	tiotropium bromide	SPRAY, METERED;INHALATION	021936-002	Sep 15, 2015		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing			Y	See Plans and Pricing
Boehringer Ingelheim	SPIRIVA RESPIMAT	tiotropium bromide	SPRAY, METERED;INHALATION	021936-002	Sep 15, 2015		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing			Y	See Plans and Pricing
Boehringer Ingelheim	SPIRIVA RESPIMAT	tiotropium bromide	SPRAY, METERED;INHALATION	021936-002	Sep 15, 2015		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing			Y	See Plans and Pricing
Boehringer Ingelheim	SPIRIVA RESPIMAT	tiotropium bromide	SPRAY, METERED;INHALATION	021936-001	Sep 24, 2014		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing			Y	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	SPIRIVA RESPIMAT	tiotropium bromide	SPRAY, METERED;INHALATION	021936-001	Sep 24, 2014	See Plans and Pricing	See Plans and Pricing
Boehringer Ingelheim	SPIRIVA RESPIMAT	tiotropium bromide	SPRAY, METERED;INHALATION	021936-001	Sep 24, 2014	See Plans and Pricing	See Plans and Pricing
Boehringer Ingelheim	SPIRIVA RESPIMAT	tiotropium bromide	SPRAY, METERED;INHALATION	021936-001	Sep 24, 2014	See Plans and Pricing	See Plans and Pricing
Boehringer Ingelheim	SPIRIVA RESPIMAT	tiotropium bromide	SPRAY, METERED;INHALATION	021936-002	Sep 15, 2015	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

See the table below for patents covering SPIRIVA RESPIMAT around the world.

Subscribe to access the full database, or Sign up for a Free Trial
Country	Patent Number	Title	Estimated Expiration
Slovenia	1017469		See Plans and Pricing
Malaysia	117247	LOCKING MECHANISM FOR A SPRING-ACTUATED DEVICE	See Plans and Pricing
Hungary	226553	METHOD FOR PRODUCING A CONTAINER HAVING A PRESSURE COMPENSATION OPENING, AND CONTAINER PRODUCED ACCORDING TO SAID METHOD	See Plans and Pricing
Denmark	0853501		See Plans and Pricing
>Country	>Patent Number	>Title	>Estimated Expiration

Subscribe to access the full database, or Sign up for a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0418716	0290010-8	Sweden	See Plans and Pricing	PRODUCT NAME: TIOTROPIUM, 3BETA-(DI(2-TIENYL)HYDROXIACETOXI)-6BETA,7BETA-EPO XI-8METYL-1ALFAH,5ALFAH-TROPANIUM, ELLER ETT SALT DAERAV; NAT. REGISRTATION NO/DATE: 18094 20020503; FIRST REGISTRATION: NL RVG 26 191 20011009
0418716	300084	Netherlands	See Plans and Pricing	PRODUCT NAME: ZOUTEN VAN TRIOTROPIUM, IN HET BIJZONDER TIOTROPIUM BROMIDE; REGISTRATION NO/DATE: RVG 26191 20011009
0418716	SPC/GB02/036	United Kingdom	See Plans and Pricing	PRODUCT NAME: SCOPINE DI-(2-THIENYL)GLYCOLATE IN THE FORM OF THE QUATERNARY SALTS - ESPECIALLY SALTS OF TIOTROPIUM - PREFERRED TIOTROPIUMBROMIDE AND TIOTROPIUMBROMIDE MONOHYDRATE; REGISTERED: NL RVG26191 20011009; UK PL14598/0062 20020514
0418716	C300084	Netherlands	See Plans and Pricing	PRODUCT NAME: ZOUTEN VAN TRIOTROPIUM, IN HET BIJZONDER TIOTROPIUM BROMIDE; REGISTRATION NO/DATE: RVG 26191 20011009
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description